GBCAs are generally thought to be safe to use in patients with good kidney function. However, retention of Gadolinium is known to have serious consequences including the incurable and potentially life-threatening disease known as Nephrogenic Systemic Fibrosis or NSF.
Background and Reference Material
As patients affected by Gadolinium Toxicity from contrast MRIs, we have been researching the topic for several years. Important findings from our research, including those that show retention of Gadolinium occurs in patients with normal kidney function, can be found throughout the pages of the Background section as well as in our Library of related reference material.